{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Obstetrical and Gynecological Survey - Vol. 75, No. 3 ((Non-Physician Credit))
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Description
The certificate for this activity is for NON-PHYSICIANS.Method of Participation in the Learning Process/Evaluation Method Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form. Getting the Most out of the Activity As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed. While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.Learning Objectives
After completing this continuing education activity you will be able to:
- CME Article 7: Medication-Assisted Treatment for Opioid Use Disorder in Pregnancy: Practical Applications and Clinical Impact-- Describe the effects of opioid use disorder on the mother-infant dyad during the antepartum, intrapartum, and postpartum periods; assess why medication-assisted treatment remains the standard of care for pregnant women with opioid use disorder; and explain the risks and benefits of different types of medication-assisted treatment and illustrate specific medication-assisted treatment initiation protocols.
- CME Article 8: Management of Anticoagulation in Pregnant Women With Mechanical Heart Valves-- Describe the clinical considerations in choosing an anticoagulation strategy for a pregnant patient with an MHV; evaluate the existing data about the safety profile of various anticoagulation strategies and the potential benefits and risks of each approach to the mother and fetus; and discuss one recommended approach to management of mechanical valves in the pregnant patient and assess the clinical nuances associated with each individual patient's decision.
- CME Article 9: Electroconvulsive Therapy in Pregnancy: Safety, Best Practices, and Barriers to Care-- Assess the current evidence and best practices regarding ECT use in pregnant patients; describe risks, benefits, and contraindications to ECT use in pregnant patients; and explain the potential for practice gaps in the utilization of ECT in pregnancy.
Disclosures
The authors, faculty and staff in a position to control the content of this CME activity, and their spouses/life partners (if any), have disclosed that they have no financial relationships with, or financial interests in, any commercial organizations relevant to this CME activity.
Off-Label UsageCME Article 8: Management of Anticoagulation in Pregnant Women With Mechanical Heart Valves Dr. Thomas G. DeLoughery has disclosed that use of enoxaparin and heparin in pregnancy has not been approved by the U.S. Food and Drug Administration as discussed in this article. Please consult the product's labeling for approved information.
Price:
$30.00
Credits:
- ACCME 3.0 CME
Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 3.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Professions:
Other Health Professional
Test Code: OGSN0320
Published: March 2020
Expires: 1/1/2026
Sources:
Obstetrical & Gynecological Survey
Required Passing Score: 9/12 (75%)
Categories:
Gynecological
,
Obstetrical
Specialties:
Gynecology,
OB/GYN